These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33011303)

  • 1. Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase.
    Caminati M; Crisafulli E; Lunardi C; Micheletto C; Festi G; Maule M; Giollo A; Orsolini G; Senna G
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1386-1388. PubMed ID: 33011303
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab.
    Chica-Guzmán MV; Morillo-Guerrero R; Carrón-Herrero A; González-de-Olano D; Almonacid-Sánchez C
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):228-230. PubMed ID: 32407950
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis.
    Condreay LD; Parham LR; Qu XA; Steinfeld J; Wechsler ME; Raby BA; Yancey SW; Ghosh S
    Rheumatol Int; 2020 Aug; 40(8):1301-1307. PubMed ID: 32009195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Pagnoux C; Groh M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
    McBrien CN; Menzies-Gow A
    Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?
    Cazzola M; Mura M; Segreti A; Mattei MA; Rogliani P
    Allergy; 2009 Sep; 64(9):1389-90. PubMed ID: 19392997
    [No Abstract]   [Full Text] [Related]  

  • 8. Early add-on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis.
    Ikeda T; Komatsu T; Yokoyama K; Takahashi K; Kawakami T
    J Dermatol; 2021 Apr; 48(4):529-532. PubMed ID: 33305381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.
    Navarro-Mendoza EP; Tobón GJ
    Curr Rheumatol Rep; 2018 Apr; 20(5):23. PubMed ID: 29611001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?
    Latorre M; Baldini C; Seccia V; Notarstefano C; Della Rossa A; Tani C; Talarico R; Mosca M; Paggiaro PL
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S91-2. PubMed ID: 23075542
    [No Abstract]   [Full Text] [Related]  

  • 11. Churg-Strauss syndrome in a patient treated with omalizumab.
    Cisneros C; Segrelles G; Herráez L; Gonzalez A; Girón R
    J Investig Allergol Clin Immunol; 2013; 23(7):515-6. PubMed ID: 24654320
    [No Abstract]   [Full Text] [Related]  

  • 12. [Churg-Strauss syndrome under omalizumab treatment: a rare visceral manifestation].
    Szwarc D; Veillon F; Moser T; Averous G; De Blay F; Riehm S
    J Radiol; 2009 Nov; 90(11 Pt 1):1737-9. PubMed ID: 19953062
    [No Abstract]   [Full Text] [Related]  

  • 13. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
    Wechsler ME; Akuthota P; Jayne D; Khoury P; Klion A; Langford CA; Merkel PA; Moosig F; Specks U; Cid MC; Luqmani R; Brown J; Mallett S; Philipson R; Yancey SW; Steinfeld J; Weller PF; Gleich GJ;
    N Engl J Med; 2017 May; 376(20):1921-1932. PubMed ID: 28514601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EOSINOPHILIC GRANULOMATOSIS WITH POLYANGITIS (EGPA)].
    Taniguchi M; Sekiya K; Kamide Y; Fukutomi Y; Watai K; Hamada Y; Nakamura Y; Ryu K; Fujita N; Yano K; Iwata M; Nagayama K; Mori A
    Arerugi; 2020; 69(5):293-303. PubMed ID: 32684542
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab administration in Churg-Strauss syndrome.
    Giavina-Bianchi P; Kalil J
    Eur J Intern Med; 2009 Oct; 20(6):e139. PubMed ID: 19782907
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of conventional immunosuppressants in relapsing or refractory eosinophilic granulomatosis with polyangiitis: evidence from a Canadian single-centre cohort.
    Doubelt I; Pulenzas N; Carette S; Pagnoux C;
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):171-175. PubMed ID: 32167871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benralizumab in eosinophilic granulomatosis with polyangiitis complicated by Staphylococcus aureus sepsis.
    Kolios AGA; Lutterotti A; Kulcsar Z; Renner T; Rudiger A; Nilsson J
    Clin Immunol; 2021 Jan; 222():108574. PubMed ID: 32805452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
    Nara M; Saito M; Abe F; Komatsuda A; Wakui H; Takahashi N
    Intern Med; 2019 Dec; 58(24):3583-3587. PubMed ID: 31391393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IgE in Churg-Strauss syndrome.
    Giavina-Bianchi P; Giavina-Bianchi M; Agondi RC; Kalil J
    Thorax; 2009 Mar; 64(3):272; author reply 272-3. PubMed ID: 19252033
    [No Abstract]   [Full Text] [Related]  

  • 20. Churg-Strauss syndrome associated with omalizumab.
    Puéchal X; Rivereau P; Vinchon F
    Eur J Intern Med; 2008 Jul; 19(5):364-6. PubMed ID: 18549941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.